Anacor Pharmaceuticals (ANAC) Stock Research, Analysis & News

Quick Analysis on Anacor Pharmaceuticals (ANAC) Stock as of August 5, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Anacor Pharmaceuticals (ANAC) Stock below)

Anacor Pharmaceuticals (ANAC) Stock Profile Summary

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing small-molecule therapeutics derived from its boron chemistry platform. The company is developing AN2690, a topical antifungal product candidate for the treatment of onychomycosis; AN2728, a topical anti-inflammatory PDE-4 inhibitor for the treatment of psoriasis; and GSK 2251052, or GSK '052, a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria, which is licensed to GlaxoSmithKline under the companies' research and development agreement. It is also developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections; and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in 2002. Anacor Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Palo Alto, California.

Anacor Pharmaceuticals (ANAC) Stock Key Statistics Research and Analysis as of August 5, 2020

Anacor Pharmaceuticals (ANAC) Stock Competitor Research and Analysis

Johnson & Johnson (JNJ)Novartis AG (NVS)
Sanofi-Aventis (SNY)

ETFs with Anacor Pharmaceuticals (ANAC) Stock in its top 10 holdings

Stock Research on Anacor Pharmaceuticals (ANAC)

Latest Market News on Anacor Pharmaceuticals (ANAC)

Click here to find the latest news on Anacor Pharmaceuticals (ANAC)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Johnson & Johnson (JNJ)
Novartis AG (NVS)
Sanofi-Aventis (SNY)